Concepedia

L Wondrack

LW

Statistics

Publications

10

Citations

2.6K

H-Index

10

Active since

1989

Affiliations

Pfizer (United States)(Current)

L Wondrack is an author at Pfizer (United States) specializing in life sciences, microbiology, and antibiotic resistance.

Publications per year

1989–2009

10

Publications

10

Detection of erythromycin-resistant determinants by PCR

Joyce A. Sutcliffe, T Grebe, Amelia Tait‐Kamradt et al. · Antimicrobial Agents and Chemotherapy · 1996 · 999 citations · Full text

, , +17

Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system

Joyce A. Sutcliffe, Amelia Tait‐Kamradt, L Wondrack · Antimicrobial Agents and Chemotherapy · 1996 · 620 citations · Full text

, , +17

mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae

Amelia Tait‐Kamradt, J. P. Clancy, Mark R. Cronan et al. · Antimicrobial Agents and Chemotherapy · 1997 · 302 citations · Full text

, , +17

Two New Mechanisms of Macrolide Resistance in Clinical Strains of <i>Streptococcus pneumoniae</i> from Eastern Europe and North America

Amelia Tait‐Kamradt, Todd A. Davies, Peter C. Appelbaum et al. · Antimicrobial Agents and Chemotherapy · 2000 · 255 citations · Full text

, , +17

Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection

Jay Bergeron, Mark Ammirati, Dennis E. Danley et al. · Antimicrobial Agents and Chemotherapy · 1996 · 154 citations · Full text

, , +17

1–5 of 10